Vishwas Setia
Vermogen: 10 M $ op 31-05-2026
Vermogen: 10 M $ op 31-05-2026
Vishwas Setia is currently Chief Financial Officer at MapLight Therapeutics, Inc. since 2024.
Formerly, Mr. Setia was an Investment Banking Summer Associate at Merrill Lynch & Co., Inc. in 2013.
Mr. Setia earned an MBA from Kellogg School of Management in 2014 and completed undergraduate studies at Delhi College of Engineering.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-05-2026 | 356.256 ( 0,84% ) | 10 M $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Financieel Directeur/CFO | 18-06-2026 |
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Corporate Officer/Principal | 01-08-2013 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Delhi College of Engineering
Delhi College of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau